Literature DB >> 2712611

A study of headaches and migraine in Sjögren's syndrome and other rheumatic disorders.

B Pal1, C Gibson, J Passmore, I D Griffiths, W C Dick.   

Abstract

Migraine occurs with increased frequency in patients with systemic lupus erythematosus and in subjects suffering from Raynaud's phenomenon without any underlying connective tissue disorders. A possible link between migraine and Raynaud's phenomenon has been suggested. Two rheumatic conditions where Raynaud's phenomenon occurs very commonly are scleroderma and primary Sjögren's syndrome. It is possible that migraine is also common in these disorders but has been unrecognised. Therefore, the prevalence of migraine was assessed by a questionnaire in 191 subjects suffering from various connective tissue disorders and control subjects. Migraine was diagnosed in 16/35 (46%) patients with primary Sjögren's syndrome, 31/97 (32%) patients with scleroderma, 4/33 (12%) patients with rheumatoid arthritis/Sjögren's syndrome compared with 3/26 (11%) control subjects. A family history of headaches was more common in the patient groups than controls. There was a significant association between occurrence of Raynaud's phenomenon and migraine. Small vessel pathology may underlie both migraine and Raynaud's phenomenon in these connective tissue disorders--as has been suggested in systemic lupus erythematosus. The findings stress the need to ask specifically about complaints of headaches/migraines in patients with scleroderma and primary Sjögren's syndrome for the appropriate total management of these patients.

Entities:  

Mesh:

Year:  1989        PMID: 2712611      PMCID: PMC1003747          DOI: 10.1136/ard.48.4.312

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Sjogren's syndrome. I. Sicca components.

Authors:  K Whaley; J Williamson; D M Chisholm; J Webb; D K Mason; W W Buchanan
Journal:  Q J Med       Date:  1973-04

3.  Is variant angina the coronary manifestation of a generalized vasospastic disorder?

Authors:  D Miller; D D Waters; W Warnica; J Szlachcic; J Kreeft; P Théroux
Journal:  N Engl J Med       Date:  1981-03-26       Impact factor: 91.245

4.  Central nervous system lupus--diagnosis and treatment.

Authors:  G R Hughes
Journal:  J Rheumatol       Date:  1980 May-Jun       Impact factor: 4.666

5.  Migrainous phenomena in systemic lupus erythematosus.

Authors:  K D Brandt; S Lessell
Journal:  Arthritis Rheum       Date:  1978 Jan-Feb

6.  A study of migraine in systemic lupus erythematosus.

Authors:  D A Isenberg; D Meyrick-Thomas; M L Snaith; R O McKeran; J P Royston
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

7.  Prevalence of Raynaud's phenomenon in patients with migraine.

Authors:  I Zahavi; A Chagnac; R Hering; S Davidovich; A Kuritzky
Journal:  Arch Intern Med       Date:  1984-04

8.  Cutaneous manifestations of primary Sjögren's syndrome: a reflection of vasculitis and association with anti-Ro(SSA) antibodies.

Authors:  E L Alexander; T T Provost
Journal:  J Invest Dermatol       Date:  1983-05       Impact factor: 8.551

  8 in total
  13 in total

Review 1.  CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.

Authors:  M Govoni; M Padovan; N Rizzo; F Trotta
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Migraine aura pathophysiology: the role of blood vessels and microembolisation.

Authors:  Turgay Dalkara; Ala Nozari; Michael A Moskowitz
Journal:  Lancet Neurol       Date:  2010-03       Impact factor: 44.182

3.  Prevalence and classification of headache in patients with systemic lupus erythematosus.

Authors:  Bruno Lessa; Alex Santana; Isabella Lima; José Martônio Almeida; Mittermayer Santiago
Journal:  Clin Rheumatol       Date:  2006-01-26       Impact factor: 2.980

Review 4.  Raynaud's phenomenon: its relevance to scleroderma.

Authors:  J J Belch
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

5.  Anti-beta2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism.

Authors:  Sharon Hassin-Baer; Yair Levy; Pnina Langevitz; Sasson Nakar; Michael Ehrenfeld
Journal:  Clin Rheumatol       Date:  2006-10-21       Impact factor: 2.980

6.  The association of Raynaud's syndrome with rheumatoid arthritis--a meta-analysis.

Authors:  Peter Hartmann; Melvin Mohokum; Peter Schlattmann
Journal:  Clin Rheumatol       Date:  2011-04-02       Impact factor: 2.980

7.  [Primary headaches and the influence of inflammatory diseases of the CNS and their respective immunmodulatory therapy].

Authors:  M Empl; A Straube
Journal:  Schmerz       Date:  2007-10       Impact factor: 1.107

Review 8.  Migraine and the risk for stroke and cardiovascular disease.

Authors:  Simona Sacco; Tobias Kurth
Journal:  Curr Cardiol Rep       Date:  2014-09       Impact factor: 2.931

9.  Evaluation of the Safety of Calcitonin Gene-Related Peptide Antagonists for Migraine Treatment Among Adults With Raynaud Phenomenon.

Authors:  Ilana D Breen; Caitlin M Brumfiel; Meera H Patel; Richard J Butterfield; Juliana H VanderPluym; Leroy Griffing; Mark R Pittelkow; Aaron R Mangold
Journal:  JAMA Netw Open       Date:  2021-04-01

Review 10.  Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms.

Authors:  Leonardo Biscetti; Gioacchino De Vanna; Elena Cresta; Ilenia Corbelli; Lorenzo Gaetani; Letizia Cupini; Paolo Calabresi; Paola Sarchielli
Journal:  J Neuroinflammation       Date:  2021-11-08       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.